TY  - JOUR
AU  - Berard, Emilie
AU  - Röllig, Christoph
AU  - Bertoli, Sarah
AU  - Pigneux, Arnaud
AU  - Tavitian, Suzanne
AU  - Kramer, Michael
AU  - Serve, Hubert
AU  - Bornhäuser, Martin
AU  - Platzbecker, Uwe
AU  - Müller-Tidow, Carsten
AU  - Baldus, Claudia D
AU  - Martinez-Cuadron, David
AU  - Serrano, Josefina
AU  - Martinez-Sanchez, Pilar
AU  - Arboli, Eduardo Rodriguez
AU  - Gil, Cristina
AU  - Bergua, Juan
AU  - Bernal, Teresa
AU  - de la Fuente Burguera, Adolfo
AU  - Delabesse, Eric
AU  - Bidet, Audrey
AU  - Dumas, Pierre-Yves
AU  - Montesinos, Pau
AU  - Recher, Christian
PY  - 2022
DO  - 10.1038/s41408-022-00700-x
UR  - http://hdl.handle.net/10668/19518
T2  - Blood cancer journal
AB  - In a context of therapeutic revolution in older adults with AML, it is becoming increasingly important to select patients for the various treatment options by taking account of short-term efficacy and toxicity as well as long-term survival. Here, the...
LA  - en
PB  - Nature Publishing Group
KW  - Leukemia, myeloid, acute
KW  - Mutation
KW  - Neoplasm recurrence, local
KW  - Nuclear proteins
KW  - Aged
KW  - Humans
KW  - Nucleophosmin
KW  - Prognosis
KW  - Registries
TI  - A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries.
TY  - research article
VL  - 12
ER  -